Skip to main content
. Author manuscript; available in PMC: 2017 Jun 5.
Published in final edited form as: J Infect Chemother. 2015 Jun 9;21(9):663–667. doi: 10.1016/j.jiac.2015.05.011

Table 3.

Posaconazole trough plasma levels by category

Number Median (Range) Number Median (Range) p value
Female Male
D2 H0 9 200 (140–660) 9 290 (120–770) 0.86
D4 H0 10 300 (140–1820) 8 580 (260–1090) 0.04
D10 H0 7 770(140–2450) 6 800 (370–1690) 0.84
BSA<1.9m2 BSA>1.9m2
D2 H0 8 380 (170–660) 10 190 (120–770) 0.27
D4 H0 9 290 (140–1820) 9 420 (250–1090) 0.22
D10 H0 7 810 (380–2450) 6 500 (140– 1690) 0.23
No IFI IFI
D2 H0 13 350(140–770) 5 170 (120–270) 0.08
D4 H0 14 410 (200–1820) 4 310 (140–470) 0.19
D10 H0 11 810 (140–2450) 2 640 (510–770) 0.77
No G3/4 LFT abnormalities LFT abnormalities
D2 H0 15 200 (140–770) 3 270 (120–490) 0.74
D4 H0 16 410 (140–1820) 2 270 (250–290) 0.21
D10 H0 11 540 (140–2450) 2 980 (770–1180) 0.64

Plasma posaconazole levels presented as ng/ml.

D, day; H, hour; BSA, body surface area; IFI, invasive fungal infection; G, grade; LFT, liver function test